A drug company is developing a new medicine. Some people argue that the medicine should be given to patients as soon as it has passed preclinical testing, without any clinical trials.
Give one argument in favour of giving the medicine to patients without clinical trials.
Explain two risks of giving the medicine to patients without clinical trials.
Explain why the results of a clinical trial are published only after they have been peer reviewed.
176 exam-style questions on AQA GCSE Biology 3.1 Communicable diseases, covering 3.1.1 Communicable (infectious) diseases, 3.1.2 Viral diseases, 3.1.3 Bacterial diseases, 3.1.4 Fungal diseases, 3.1.5 Protist diseases, 3.1.6 Human defence systems, 3.1.7 Vaccination, 3.1.8 Antibiotics and painkillers, and 3.1.9 Discovery and development of drugs. Each one has a worked solution and a mark scheme showing where the marks go.